NSE · Healthcare · Drug Manufacturers - Specialty & Generic
EPS came in at 3.00 against a street estimate of 3.90 — a miss of 23.1%.
| Document | Date |
|---|---|
| Annual report FY2026 BLISS GVS PHARMA LIMITED - ANNUAL REPORT FY2025-26 SUMMARY HEADLINE NUMBERS • Consolidated Revenue: ₹9,271 million • Standalone Revenue: ₹7,298 mill | 2026-06-23 |
| Quarterly results · Q4 FY26 BLISS GVS PHARMA LIMITED – COMPANY DOCUMENT SUMMARY HEADLINE NUMBERS • Net Profit (Standalone) for FY ended March 31, 2026: Rs. 3,242.25 lakh • Net | 2026-05-12 |
| Quarterly results · Q2 FY26 BLISS GVS PHARMA LIMITED – BOARD MEETING SUMMARY November 06, 2025 --- HEADLINE NUMBERS • Board meeting held on Thursday, November 06, 2025 at compa | 2025-11-06 |
| Quarterly results · Q1 FY26 BLISS GVS PHARMA LIMITED - BOARD MEETING SUMMARY HEADLINE NUMBERS • Quarter ended: June 30, 2025 • Financial results status: Unaudited Standalone an | 2025-07-29 |
| Annual report FY2025 | 2025-07-09 |
| Quarterly results | 2025-01-28 |
| Quarterly results | 2024-10-24 |
| Quarterly results | 2024-07-24 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹1 / share ex-date Jul 8, 2026 | 2026-07-08 |
| Dividend | ₹0.50 / share ex-date Feb 18, 2026 | 2026-02-18 |
| Announcement | Date |
|---|---|
| Open offer by acquirer for addition of PAC Anupam Rasayan Limited, acting as an acquirer, has made an open offer to purchase shares in a company (referred to as PAC in the announcement). SBI Capital Markets Limited, the financial adv | 2026-07-20 |
| Addendum to public announcement for open offer acquisition Bliss GVS Pharma Limited announced an addendum (supplementary document) to the public announcement and detailed public statement regarding an open offer by Anupam Rasayan Limited, who is acq | 2026-07-19 |
| Interim dividend of Rs. 0.50 per equity share declared Bliss GVS Pharma Limited's Board of Directors declared an interim dividend of Rs. 0.50 per equity share on February 10, 2026. Key Details: - Dividend Amount: Rs. 0.50 per share - Type: Inte | 2026-02-10 |
| Interim dividend of 0.50 per equity share declared Bliss GVS Pharma Limited's Board of Directors declared an interim dividend of ₹0.50 per equity share on February 10, 2026. Key Details: - Dividend Amount: ₹0.50 per share - Type: Interim di | 2026-02-10 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Bliss GVS Pharma Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.